ACT Genomics Hong Kong

ACT Genomics Hong Kong office was established in January 2017 to meet the growing cancer needs in Hong Kong. In Hong Kong, there were 29,618 new cancer cases diagnosed in 2014, which increased 2.4% compared with 2013 according to the Hong Kong Cancer Registry. We are a team of experts with years of experience in oncology, cancer genomics, and bioinformatics, aiming to provide treatment guidance and disease monitoring with better precision for cancer patients.



Recent Events

2019.07.04 & 24  ACT Genomics Hong Kong Lab Grand Opening

ACT Genomics opened its third Next Generation Sequencing laboratory in Asia at the Hong Kong Science Park on July 4, 2019. Cocktail reception and lab tour were held on July 24.


ACT Genomics Hong Kong Lab Grand Opening

ACT Genomics Hong Kong Lab Cocktail Reception & Lab Tour



2019.06.29 Precision Treatment for Lung Cancer Patients Symposium

Precision Treatment for Lung Cancer Patients Symposium was held on June 29, 2019 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong Precision Oncology Society(HKPOS), and sponsored by ACT Genomics.


Dr. Shu Jen Chen on "Biomarkers in Drug Selection for Lung Cancer Treatment"

Dr. Jacky Yu-Chung Li on "Targeted Treatment for Lung Cancer"

Dr. Chun-Ming Tsai on "Clinical Application of NGS in lung cancer management"

Event Highlights of Precision Treatment for Lung Cancer Patients Symposium



2018.10.10 The 5th Hong Kong International Oncology Symposium

The 5th Hong Kong International Oncology Symposium  was held on October 10, 2018 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong Precision Oncology Society(HKPOS), and sponsored by ACT Genomics.


Event Highlights of The 5th Hong Kong International Oncology Symposium


2017.09.21 Precision Oncology Symposium Session III: Lung Cancer

Precision Oncology Symposium Session III: Lung Cancer was held on September 21, 2017 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong Lung Cancer Study Group (HKLCSG), and sponsored by ACT Genomics.






Full Version - 2017 Precision Oncology Symposium - Lung Cancer - Hong Kong

Dr. Jacky Yu-Chung Li on "Go Beyond Resistance"

Dr. Shu Jen Chen on "Clinical Application of NGS on Lung Cancer Management"

Q&A Session - Lung Cancer

2017.06.15 Precision Oncology Symposium Session II: Colorectal Cancer

Precision Oncology Symposium Session II: Colorectal Cancer was held on June 15, 2017 and featured a series of presentations by experts in the field. The symposium was hosted by Hong Kong College Of Radiologists and Hong Kong Society of Clinical Oncology, and sponsored by ACT Genomics.








2017 Precision Oncology Symposium - Colorectal Cancer in Hong Kong

Dr. Chi Leung Chiang on "Management of Metastatic Colorectal Cancer (mCRC)"

Dr. Siu-Kie Au on "Molecular Classification of Colorectal Cancer"

Dr. Jensen Poon on "Surgical Management of Colorectal Cancer"

Dr. Shu Jen Chen on "NGS and Precision Management of Colorectal Cancer"

Q&A Session - Colorectal Cancer


2017.05.10 Precision Oncology Symposium Session I: Breast Cancer

Hosted by the Hong Kong Breast Oncology Group and ACT Genomics, Precision Oncology Symposium Session I: Breast Cancer was held on May 10, 2017 and featured a series of presentations by experts in the field.








Event Highlights of Breast Cancer Precision Oncology Symposium

Dr. Lorraine Chow on "Surgical Management of Breast Cancer"

Dr. Joseph Au on "Genomics Assay and Adjuvant Treatment Decision-Making"

Dr. Janice Tsang on "Targeted Therapies for Breast Cancer"

Dr. Shu Jen Chen on "NGS Application for Management of Breast Cancer"

Welcome to ACT Genomics Hong Kong

Contact

To find out more about our services, get in touch with us at

ACT Genomics Hong Kong

Tel: +852 2186 9600

Fax: +852 2186 9699

Office: Units 803 – 807, 8F, Building 15W, No.15 Science Park West Avenue, Hong Kong Science Park, Pak Shek Kok. NT, Hong Kong

Email: service.hk@actgenomics.com

We look forward to hearing from you .